Stericycle Reaches New 52-Week High (SRCL)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Stericycle Incorporated (Nasdaq: SRCL) hit a new 52-week high Tuesday as it is currently trading at $110.34, above its previous 52-week high of $110.30 with 164,428 shares traded as of 1:46 p.m. ET. Average volume has been 506,000 shares over the past 30 days.

Stericycle has a market cap of $9.4 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 17.1% year to date as of the close of trading on Monday.

Stericycle, Inc., together with its subsidiaries, provides regulated waste management and related services. The company has a P/E ratio of 34.4, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Stericycle as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Stericycle Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

The Value of an Overvalued Market: Cramer's 'Mad Money' Recap (Thursday 8/10/17)

Wide Moat, Bargain Price

Analysts' Actions -- Akamai, Estee Lauder, Hess, Ferrari and More

Stericycle Setting Up for a Breakout

Stericycle Started With 'Overweight' Rating at Barclays